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ABSTRACT
Using human embryonic, adult and cancer stem
cells/stem cell-like cells (SCs), we demonstrate that
DNA replication speed differs in SCs and their dif-
ferentiated counterparts. While SCs decelerate DNA
replication, differentiated cells synthesize DNA faster
and accumulate DNA damage. Notably, both replica-
tion phenotypes depend on p53 and polymerase iota
(POL). By exploring protein interactions and newly
synthesized DNA, we show that SCs promote com-
plex formation of p53 and POL at replication sites.
Intriguingly, in SCs the translocase ZRANB3 is re-
cruited to POL and required for slow-down of DNA
replication. The known role of ZRANB3 in fork rever-
sal suggests that the p53–POL complex mediates
slow but safe bypass of replication barriers in SCs. In
differentiated cells, POL localizes more transiently
to sites of DNA synthesis and no longer interacts with
p53 facilitating fast POL-dependent DNA replication.
In this alternative scenario, POL associates with
the p53 target p21, which antagonizes PCNA poly-
ubiquitination and, thereby potentially disfavors the
recruitment of translocases. Altogether, we provide
evidence for diametrically opposed DNA replication
phenotypes in SCs and their differentiated counter-
parts putting DNA replication-based strategies in the
spotlight for the creation of therapeutic opportunities
targeting SCs.
INTRODUCTION
Increasing evidence suggests an interplay between the DNA
damage response (DDR) and the epithelial–mesenchymal
transition (EMT) (1,2) a pathway activated during the ac-
quisition of stem cell (SC) properties (3). Stem cells main-
tain self-renewal capacity and genomic stability by means
of highly efficient DDR cascades, which lose precision when
cells differentiate (4,5). While the association between DNA
repair mechanisms and stemness has been intensively in-
vestigated (4), the crosstalk between SC features and other
DDR mechanisms such as DNA damage tolerance (DDT)
is less understood. Information was gathered mostly in the
hematopoietic system using mouse models (6), and is insuf-
ficient, especially given that mice and human models differ
significantly at the level of DDR activation in SCs (7,8).
Because of its role in transcriptional transactivation (TA)
(9), the tumor suppressor protein p53 is a critical regula-
tor of cancer cell plasticity (10,11), promoting differentia-
tion of SCs (11,12), impacting on lineage choice (13) and
repressing EMT (14). However, p53 also maintains the self-
renewal capacity of human hematopoietic SCs (HSCs) (15),
suggesting opposed functions of p53 in stem and differen-
tiated cells. Interestingly, a TA-independent DDT role of
p53 possibly involving the formation of a p53–POL com-
plex has been reported in cycling HSCs and progenitors
(HSPCs) (16,17). It has been proposed that the coordina-
tion of POL-polymerase and p53’s exonuclease activities
mediates idling events, i.e. iterative insertion and degrada-
tion of nucleotides, a function achieved by some other DNA
polymerases (18). Idling generates a dynamic stalling, which
correlates with augmented poly-ubiquitination of prolifer-
ating cell nuclear antigen (PCNA) by the ubiquitin ligase
Rad5-related helicase-like transcription factor (HLTF) and
involves the SWI/SNF catalytic subunit (SNF2) translocase
zinc finger ran-binding domain containing 3 (ZRANB3).
Given the established role of ZRANB3 in fork reversal (19)
it is most likely that the p53–POL idling pathway involves
fork reversal (FR) events.
Herein we explore the relevance of p53 for DDT in stem
and differentiated cells, focusing on the role of the p53–
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POL pathway. When analyzing replication phenotypes in
human embryonic, adult and cancer SCs and differenti-
ated counterparts, we revealed an unexpected association
between the differentiation stage and the DDT pathway
choice. Remarkably, p53 and POL are key for both choices.
While SCs engaged a p53–POL mediated DDT, differenti-
ated cells are biased towards a faster bypass mechanism that
does not depend on the p53–POL complex, but depends on
each protein individually.
MATERIALS AND METHODS
Please refer to Supplementary Material and Methods for
further details.
Cell cultures
All cells were cultured at 37◦C, 5% CO2 and ambient O2.
Ovarian cancer cell differentiation was induced by removal
of growth factors and addition of 10% FBS (Merck, Darm-
stadt, Germany) for seven days as described in Ricci et al.
(20). HSPCs and PBLs were isolated from cord blood sam-
ples with consent of the parents and the approval by the
local advisory boards (approval #155/13 from the Eth-
ical Board of Ulm University). Human embryonic stem
cells (hESCs) were cultured as in Luft et al. (21) and ex-
periments were performed in the laboratories of the GSI
Helmholtz Center for Heavy Ion Research, Darmstadt,
Germany in the Group of Stem Cell Differentiation and Cy-
togenetics, Department of Biophysics (authorization num-
bers 3.0402/0069 and 3.04.02/006-E01) supervised by Insa
Schroeder. Further details of isolation of hematopoietic
cells as well as cell culturing of hESCs are described in the
Supplementary Material and Methods.
Transfection
The plasmids as well as siRNAs, which were used for cell
transfection are described in detail in the Supplementary
Material and Methods.
hESCs were transfected using siRNAs and HiPerFect
(Qiagen, Hilden, Germany). After 24 h medium was
changed and after in total 48 h the experiments were con-
ducted.
Silencing of p53 and POL in HSPCs and PBLs was
achieved by nucleofection with the Amaxa Human B
cell nucleofector solution (Lonza, Walkersville, Maryland,
USA) and the Amaxa Device II (Lonza). 1 × 106 cells
were mixed with 10g plasmid and 100l Amaxa nu-
cleofector solution. After applying program U-008 for
HSPCs or U-015 for PBLs, HSPCs were immediately trans-
ferred to their standard medium, whereas PBLs were cul-
tured in RPMI medium (Gibco by Thermo Fisher Scien-
tific, Waltham, Massachusetts, USA) containing 1% (v/v)
Penicillin/Streptomycin (Gibco by Thermo Fisher Scien-
tific) and 20% (v/v) FBS (Biochrom by Merck, Darm-
stadt, Germany). 4h post-transfection 2% Phytohemagglu-
tinin (Gibco by Thermo Fisher Scientific) was added. Ex-
periments were carried out 24 h post-transfection.
Ovarian cancer cell lines were transfected using the
Amaxa Device II and the Amaxa Cell line nucleofector
Solution V (Lonza). In 100 l nucleofector solution a to-
tal amount of 10 g plasmid were mixed with 2 × 106
cells and transfected using program W-001. For double-kd,
also 10 g (5 + 5) plasmid were used. Cells were seeded in
their standard medium und used for experiments 24 h post-
transfection.
Determination of cell viability
The colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay was used
following manufacturers instruction (Sigma-Aldrich by
Merck, Darmstadt, Germany). Consumption of nicoti-
namide adenine dinucleotide (NAD+), mainly generated
during glycolysis was measured by the colorimetric 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. MTT was performed 24 h post-transfection
for measurement of the metabolic activity as indicator for
cell viability. Cells were incubated with 0.5 mg/ml MTT
(Sigma-Aldrich by Merck, Darmstadt, Germany) for 3 h
and then fixed for 15 min with 0.04 M HCl diluted in
2-propanol solution before light absorbance was measured
at 570 nm with an ELISA reader. Each data set of the cell
viability measurement was normalized to the mean value
of the corresponding control samples.
Cell cycle distribution
Propidium iodide staining was performed as previously de-
scribed by us (17). To determine the fraction of cells in
the different cell cycle phases, nd and diff cells were har-
vested and collected by centrifugation (for diff cells after
trypsinization of adherently growing cells and cells float-
ing in the supernatant). After washing with PBS and re-
suspension in 0.5 ml of PBS, cells were fixed by adding ice-
cold 4.5 ml fixing solution (acetone and 80% (v/v) ethanol
(1:1)) dropwise. Then cells were washed twice with cold PBS
and resuspended in 200 l propidium iodide staining so-
lution (50 g/ml PI in PBS) supplemented with 50 g/ml
RNase A (both Sigma-Aldrich by Merck, Darmstadt, Ger-
many). After 30 min incubation in the dark, the samples
were further diluted by adding 100 l PBS with 0.2% EDTA
and measured in a FACSCalibur flow cytometer (BD Bio-
sciences, Franklin Lakes, New Jersey, USA). Percentages of
G1-, S- and G2-phase cells were calculated in the live cell
fraction.
Determination of S-Phase length: CldU/IdU double labeling
The difference of S-Phase length between nd and diff cells
was determined by double labelling of the cells with CldU
and IdU according to the protocol of Charrasse et al.
(2017) with EdU/BrdU double labelling (22). In brief, diff
cells were grown in chamber slides (Falcon® Culture Slides
4-well, OMNILAB, Bremen, Germany) whereas nd cells
were cultured in 6-well and later on spun onto poly-L-
lysine coated slides via cytospinning. Cells were pulsed with
10 M CldU for 30min. Followed by incubation in medium
supplemented with 5M thymidine for either 2, 4, 6, 8 or
10 h. Afterwards, cells were pulsed again in 10 M IdU
for 30 min. Then the cells were incubated for 1min in pre-
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HEPES (pH 7.4), 3 mM MgCl2, 1 mM EDTA, 0.5% (v/v)
Triton X-100 in water) for diff cells directly after incubation
or for nd cells after cytospinning. Cells were fixed with 3.7%
formaldehyde, permeabilized for 12 min with 0.5% Triton
X-100 in PBS and denatured for 20 min in 4 N HCl. Finally,
cells were blocked and stained as described in the paragraph
‘DNA Fiber Spreading Assay’. Cells were visualized with a
BZ-9000 microscope (Keyence, Cologne, Germany) and a
40× objective. Counting of the stained cells was carried out
with the Fiji (Fiji is just ImageJ) software (ImageJ Wiki,
Laboratory for Optical and Computational Instrumenta-
tion, University of Wisconsin-Madison, Wisconsin, USA).
Coimmunoprecipitations
Co-IPs were performed 24 h post-seeding following pre-
viously described methods (17,23). Chromatin extracts
were obtained by incubation for 12 min at 4◦C with Cy-
toskeletal buffer (250 mM Sucrose, 25 mM KCl, 1 mM
HEPES (pH 7.5), 1 mM EGTA, 1 mM MgCl2 in wa-
ter) with freshly added inhibitors: 1 mM phenylmethylsul-
fonylflouride (PMSF), 1 mM Na3VO4, protease inhibitor
cocktail (Roche, Basel, Switzerland) and 0.1 mM dithio-
threitol (DTT). Crosslinking was carried out by adding 1%
(v/v) methanol-free formaldehyde in PBS and incubating
for 10 min at RT. Afterwards, cells were put on ice and
10 mM cold Glycine was added for 5 min to stop crosslink-
ing. Cells were then lysed with RIPA buffer (10 mM Tris–
HCl (pH 7.5), 25 mM sodium-fluoride, 20 mM sodium-
chloride, 1% (v/v) sodium-deoxycholate, 1% (v/v) Nonidet
P40, 0.1% SDS in water) with freshly added protease in-
hibitors (mentioned above) and 0.1 mM DTT. After 15 min
incubation cells were harvested and sonified in a sonifi-
cation water bath Sonorex (Bandelin electronic GmbH &
Co. KG, Berlin, Germany) at high power three-times each
7.5 min: 30 s on, 30 s off. Supernatant was harvested by cen-
trifugation and used for immunoprecipitation of p53 with
antibodies Pab421 (mouse, OP03, Calbiochem, Darmstadt,
Germany) and Pab1801 (mouse, OP09, Calbiochem) as well
as of PCNA with anti-PCNA (mouse, ab29, Abcam, Cam-
bridge, UK). Isotype control was performed by using nor-
mal IgG (mouse, sc-2027, Santa Cruz Biotechnology, Dal-
las, TX, USA). Protein extracts and Protein G Sepharose
beads (PGS, GE Healthcare, Munich, Germany), as well as
antibodies and PGS beads were incubated overnight at 4◦C.
The next day protein extracts were transferred to antibody-
bead mixes and rotated for another 4 h at 4◦C. Afterwards
beads and bound proteins were dissolved and denatured us-
ing SDS-PAGE sample buffer.
Western blot analysis
For the analysis of protein levels, cells were lysed 24–
48 h post-seeding or transfection. Protein extracts were
then separated electrophoretically and transferred to acti-
vated PVDF membranes. Proteins were immunodetected
via chemi-luminescence (24). Briefly, for cell lysis 50 mM
Tris–base (pH 7.4), 150 mM NaCl, 2 mM EGTA, 2 mM
EDTA, 25 mM sodium fluoride, 25 mM -glycerol phos-
phate, 0.1 mM sodium vanadate, 0.2% triton X-100 and
0.3% Nonidet P40 were used. Protein levels were adjusted
and after SDS-polyacrylamide-gel electrophoresis blotted
onto PVDF membranes (Amersham by GE Healtcare, Mu-
nich, Germany). The antibodies, which were used for pro-
tein detection are described in detail in the Supplementary
Material and Methods section. Chemiluminescence detec-
tion of protein levels as well as quantification of band in-
tensities were done in the linear range using ImageLab soft-
ware on a ChemiDocMP system (Bio-Rad Laboratories,
Munich, Germany). Values of target genes were corrected
for the loading control.
Quantitative reverse transcription PCR (qRT-PCR)
For detection of special candidate genes, stemness and
EMT markers quantitative PCR after reverse transcrip-
tion of mRNA was used as previously described (17). Total
mRNA was isolated 24 h after seeding by using the RNeasy
Mini Kit (Qiagen, Hilden, Germany). Reverse transcrip-
tion was performed with the help of the QuantiTect Reverse
Transcription Kit (Qiagen, Hilden, Germany). For qRT-
PCR TaqMan® probes were used and the SensiFASTTM
Probe Lo-ROX Kit (Bioline, Memphis, Tennessee, USA).
qPCR was conducted with the Viia7 RUO thermocycler
(Applied Biosystems). mRNAs of the target genes were de-
tected with TaqMan® assays (all Thermo Fisher Scientific,
Waltham, MA, USA) as described in detail in the Supple-
mentary Material and Methods section. Values of target
genes were normalized to mean values of both housekeep-
ing genes and calculated with the comparative cycle thresh-
old method (2-Ct). Finally, each data set was normalized
to the value of nd cells.
DNA fiber spreading assay
DNA fiber spreading assay was performed according to
Speroni et al. (25). Cells were labelled 24–48 h post-
seeding/transfection with 20 M 5-chloro-2-deoxyuridine
(CldU, Sigma-Aldrich by Merck, Darmstadt, Germany)
for the indicated times, then washed with pre-warmed
PBS, followed by a second labelling with 200 M 5-
iodo-2-deoxyuridine (IdU, Sigma-Aldrich). Cells were then
washed, harvested and resuspended. 2500 cells per slide
were lysed with 6 l lysis buffer (0.5% SDS, 100 mM Tris–
HCl (pH 7.4), 50 mM EDTA) for 6 min at RT. Slides were
then tilted ∼20◦ to allow the spreading of DNA via grav-
ity. After further 6min drying, DNA was fixed on the slides
by incubation for 5min with methanol-acetic acid solution
(3:1). When slides were dried for another 7 min they could
be stored in 70% (v/v) ethanol at 4◦C overnight or directly
be subjected to denaturation/deproteination in 2.5 M HCl
for 1h, followed by immunofluorescence staining. Blocking
with 5% (w/v) bovine serum albumin in PBS for 45 min
at 37◦C was followed by incubation with a primary anti-
body mix of anti-BrdU detecting IdU (mouse, #347580,
BD, Franklin Lakes, NJ, USA) and anti-BrdU detecting
CldU (rat, ab6326, Abcam, Cambridge, UK) for 1 h at RT.
Finally, slides were incubated with a mix of secondary an-
tibodies, AlexaFluor555 (anti-mouse) and AlexaFluor488
(anti-rat, both secondary antibodies were from Invitro-
gen by Thermo Fisher Scientific, Waltham, MA, USA) for
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microscope (Keyence, Cologne, Germany) and a 40× objec-
tive. Measurement of the DNA fiber track length was car-
ried out with the Fiji (Fiji is just ImageJ) software (ImageJ
Wiki, Laboratory for Optical and Computational Instru-
mentation, University of Wisconsin-Madison, WI, USA).
Immunofluorescence staining
Cells were either grown in chamber slides (Falcon® Cul-
ture Slides 4-well, OMNILAB, Bremen, Germany) or in
case of suspension culture cells were spun onto poly-L-
lysine coated slides via cytospinning. Following fixation
and antibody staining was performed according to Hampp
et al. (17). In brief, after a possible 1min treatment with
pre-extraction buffer (ingredients see paragraph ‘Determi-
nation of S-Phase length’) cells were fixed in 3.7% (v/v)
formaldehyde in PBS and permeabilized with 0.5% (v/v)
Triton X-100 (Sigma-Aldrich by Merck, Darmstadt, Ger-
many). After blocking with 5% (v/v) goat-serum in PBS
for 1 h at RT, cells were immunostained for 1 h at 37◦C.
The following primary antibodies were mixed as indi-
cated in the figures and used: anti-53BP1 (rabbit, NB100-
304, Novus Biologicals, Cambridge, UK), anti-phospho-
histone H2A.X (Ser139, mouse, #05-636, Merck Millipore,
Darmstadt, Germany) and anti-POL (rabbit, PA5-29442,
Thermo Fisher Scientific). Afterwards, slides were incu-
bated for 45 min at 37◦C with a mix of secondary antibod-
ies AlexaFluor555 (anti-rabbit) and AlexaFluor488 (anti-
mouse, both secondary antibodies were from Invitrogen by
Thermo Fisher Scientific, Waltham, MA, USA). Slides were
mounted with Vectashield containing DAPI (Vector Labo-
ratories, Burlingame, California, USA) and a coverslip. Im-
munofluorescence of nuclear signals was measured with a
BZ-9000 microscope (Keyence, Cologne, Germany) and a
100× oil immersion objective. Automated quantification of
foci was done with the BZ-II Analyzer software (Keyence).
Within one data set intensity threshold and minimal foci
size were maintained.
In situ proximity ligation assay
PLA was performed according to the manufacturer’s in-
structions (DUO92002, Sigma-Aldrich by Merck, Darm-
stadt, Germany). Cells were grown and spun on slides as
for immunofluorescence staining. Then cells were incubated
for 1 min with pre-extraction buffer (for ingredients see
paragraph ‘Determination of S-Phase length’) before they
were fixed in 3.7% (v/v) formaldehyde in PBS. For PLA
we used Duolink In Situ PLA Orange Kit Mouse/Rabbit
(Sigma-Aldrich by Merck, Darmstadt, Germany). Slides
were blocked for 1 h at RT with the blocking solution
of the kit. Afterwards, cells were double-stained with a
mix of primary antibodies, which are described in detail
in the Supplementary Material and Methods. PLA staining
was then performed using the PLA probes of the Duolink
kit: PLA probe anti-rabbit PLUS (anti-rabbit IgG (H+L);
DUO92002, Sigma-Aldrich by Merck, Darmstadt, Ger-
many) and PLA probe anti-mouse MINUS (anti-mouse
IgG (H+L), DUO92004, Sigma-Aldrich by Merck, Darm-
stadt Germany) for 1 h at 37◦C. Slides were then incubated
for ligation with the ligase solution for 30 min at 37◦C fol-
lowed by an amplification step of the hybridized labelled
oligonucleotides for 100 min at 37◦C with the polymerase
solution. Slides were then covered with Duolink In Situ
Mounting Medium with DAPI (Sigma-Aldrich by Merck)
and coverslips. Nuclear foci were visualized using BZ-9000
microscope (Keyence, Cologne, Germany). Quantification
was done with the BZ-II Analyzer software (Keyence).
In situ analysis of protein interactions at DNA replication
forks
SIRF was conducted according to Petruk and colleagues
(26,27) followed by PLA. First, cells were either grown in
chamber slides or in case of suspension culture cells on
plates. Then EdU (20 M) was incorporated for 8 min fol-
lowed by another incubation with thymidine (100 M) for a
chase period of up to 4 h. After pre-extraction (as described
for PLA) and fixation with 2% methanol-free formaldehyde
(Thermo Fisher Scientific, Waltham, MA, USA) perme-
abilization with 0.5% (v/v) Triton X-100 in PBS was fol-
lowed by a click reaction (100 mM sodium-(L)-ascorbate,
2 mM CuSO4 and 0.01 mM biotin azide in PBS). After-
wards the staining procedure was continued at the blocking
step of the PLA. Primary antibodies were used as already
described in the PLA paragraph in the Supplementary to-
gether with anti-biotin (mouse, B7653, Sigma-Aldrich by
Merck, Darmstadt, Germany or rabbit, #5597, Cell Signal-
ing, Danvers, MA, USA).
Statistics
Graphic presentation of data was carried out using Graph-
Pad Prism 8 software. Data was shown as mean ± SEM
or mean ± SD, as stated in the figure legends. For related
values significances were calculated by Wilcoxon matched-
pairs signed rank test (two-sided) whereas, for the other
data Mann–Whitney U test (two-sided) was used, which was
preceded by Kuskal–Wallis test when comparing groups
with more than two samples.
RESULTS
The nascent DNA elongation rate is lower in SCs than in dif-
ferentiated counterparts
Changes in the nascent DNA elongation rate affect ge-
nomic instability and cell death (28). However, its rele-
vance for other biologically relevant outputs such as stem-
ness has remained underexplored. Therefore, we examined
nascent DNA replication rates in pairs of isogenic non-
differentiated (nd) and differentiated (diff) samples. Human
embryonic stem cells (hESCs) derived from the H9 cell line
were differentiated into the neuronal lineage (ndiff) or spon-
taneously (sdiff), into the endoderm-like direction using
pre-established procedures (29,30) (Figure 1A). The differ-
entiation status of the cells was confirmed by assessing the
levels of: (a) the pluripotency marker Nanog (12), (b) p53
(12) and (c) the neurogenesis marker paired box 6 (PAX6)
(31) (Supplementary Figure S1A). Samples were subjected
to DNA Fiber Spreading Assays (32) performed as reported
by us before (25). Strikingly, DNA tracks in nd cells were
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Figure 1. Nascent DNA elongation in SCs and their differentiated counterparts. Nascent DNA track lengths were measured after DNA Fiber Spreading
Assays: sequential incorporation of CldU (20 min) and IdU (30 min) in B and G and of CldU (20min) and IdU (20 min) in D, results from two to
three independent experiments. Only IdU track measurements from bi-colored fibers are depicted for clarity here but similar results were obtained when
analyzing CldU tracks. In B, D, F, G: mean ± SEM. **P ≤ 0.01, ****P ≤ 0.0001 (B, D, G: Mann–Whitney U test, two-sided F: Wilcoxon matched-pairs
signed rank test, two-sided). (A) Schematic representation of differentiation of non-differentiated (nd) hESCs either spontaneously (sdiff) or into neuronal
lineage (ndiff). (B) DNA Fiber Spreading Assay for nd hESCs, sdiff and ndiff cells (100–180 fibers/experiment). (C) Illustration of isolation of adult SCs
(HSPCs) and differentiated cells (PBLs) from cord blood samples using a Ficoll gradient and HSPC enrichment by CD34 MicroBead Kit. (D) DNA
Fiber Spreading Assay for HSPCs and PBLs from 1–5 donors/experiment (130–400 fibers/experiment). (E) Graphical presentation of differentiation of
nd ovarian cancer cells to differentiated (diff) cells. (F) Western blot quantification of Nestin and p53 for ovarian cancer cell line #110. Individual band
intensities were corrected by the corresponding ones for housekeeping genes (-actin, GAPDH or PCNA) followed by normalization of protein levels to
nd cells. Analysis was done for 9 (Nestin)–10 (p53) blots. (G) DNA Fiber Spreading Assay for three cell lines of ovarian cancer cells (#83, #107, #110) in
the nd and diff status each (70–200 fibers/experiment).
Secondly, we compared cycling adult HSPCs and dif-
ferentiated peripheral blood lymphocytes (PBLs) isolated
from umbilical cord blood samples (Figure 1C). DNA
tracks were on average shorter in HSPCs than in PBLs (Fig-
ure 1D). In agreement with its differentiation status, PBLs
showed higher p53 levels than HSPCs (Supplementary Fig-
ure S1B). Thus, adult SCs also revealed a slower nascent
DNA elongation rate than differentiated counterparts.
As a third line of evidence, a cancer SC model was ex-
plored. We used three cancer cell lines derived from ovar-
ian tumors of three different patients (#83, #107, #110)
enriched for tumor initiating cells (20). Such cell lines ex-
press wild-type p53 and grow as spheroids in their nd state
exhibiting SC and EMT characteristics (20). The removal
of growth factors and the addition of fetal bovine serum
(FBS) causes the loss of SC and mesenchymal properties
(20) (Figure 1E) as confirmed when monitoring relevant
markers and p53 levels (Figure 1F, Supplementary Figure
S1C–S1D). In all cases, DNA tracks were shorter in nd than
in diff samples (Figure 1G, representative pictures for #110
in Supplementary Figure S1E). In conclusion, in embry-
onal, adult and cancer SC models, the differentiation status
affects the rate of nascent DNA elongation.
Lower DNA elongation rates in SCs are accompanied by di-
minished replication stress
The shortening of replication tracks can be the consequence
of increased origin firing. Common causes of increased ori-
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35). We therefore determined the frequency of active origins
as done in the past (33,36) but found no significant differ-
ence between nd and diff cells (Supplementary Figure S1F).
An additional source for track shortening is fork stalling,
which can be indirectly revealed as fork asymmetry (28). As
we did in the past (17), such a stalling parameter was deter-
mined by measuring the length of two IdU tracks emanat-
ing from the same origin (CldU track) (17). Interestingly, we
found a significantly increased asymmetry in diff cells when
compared to nd cells (Figure 2A), implying that the shorter
tracks of nd cells are not the result of fork stalling and are
more likely related to a slower replication rate.
In a next step, proliferation was examined, finding no
major change (Supplementary Figure S1G). Given the bet-
ter access to the samples, we focused for the further anal-
ysis of the mechanism on the cancer cell model. We then
analyzed the cell cycle distribution by flow cytometry af-
ter propidium iodide staining and noticed a statistically
significant increase of the percentage of G1 phase in nd
cells when compared with diff cells (Supplementary Figure
S1H). Moreover, we used a more sensitive method of se-
quential CldU/IdU incorporation to infer the time taken
for the progression through S-phase (22), and observed a
prolonged S-Phase in nd cells when compared to nd coun-
terparts (Supplementary Figure S1I). These data suggested
that nd cells enter and progress through S-phase more
slowly than diff cells, which is in line with the observed
slower replication speed in nd cells.
Knowing that replication-associated DNA damage load
modulates DNA replication speed and vice versa (28,37),
we monitored DDR markers such as H2AX and 53BP1
foci accumulation (Figure 2B-C). Notably, unperturbed and
mitomycin C (MMC)-treated diff cells displayed higher lev-
els of H2AX foci when compared to nd cells (Figure 2B,
left panel). While the levels of 53BP1 foci were not equiva-
lent to H2AX foci (Figure 2B, central panel), colocalized
H2AX and 53BP1 foci (Figure 2B, right panel), indicat-
ing replication-associated DSBs (37), followed the H2AX
foci pattern. H2AX foci were reported to label DNA le-
sions at sites of replication stress including but not limited
to DSBs (38). 53BP1 was shown to play an important role
in protecting reversed forks from uncontrolled restart and
end resection (39,40). Therefore, the increase in H2AX
but not 53BP1 foci in diff cells may reflect replication stress
associated with replication forks devoid of 53BP1 shield-
ing and prone to ssDNA accumulation (41,42). Confirm-
ing that diff cells may be prone to ssDNA accumulation
when compared to nd cells, immunoblot experiments re-
vealed a sharp rise in the modified form of RPA in nd cells
(phospho-RPA S33) that was hardly detected in nd cells
(Figure 2D). Given that the Ataxia telangiectasia and Rad3
related serine/threonine kinase (ATR) phosphorylates hi-
stone H2AX at Ser139 and RPA32 at Ser33 in response
to replication stress (43,44), we analyzed the activation of
the upstream kinase by immunoblotting experiments. Phos-
phorylation of ATR at Ser428 (P-ATR) relative to total
ATR rose in diff cells supporting the concept of enhanced
replication stress in diff compared to nd cells (Figure 2E).
These results suggested that, counterintuitively, the cells un-
dergoing the highest replication stress (diff cells) are the
ones synthesizing nascent DNA at a highest speed, per-
haps as a consequence of a more efficient tolerance pathway
choice.
p53 and POL promote nascent DNA elongation in differen-
tiated cells but slow down such a DNA synthesis in SC coun-
terparts
The inverse correlation between replication stress markers
and nascent DNA elongation rates in nd and diff cells sug-
gests a different usage of DDT pathways. Hypothesizing
that HSPCs use the p53- and POL-dependent DDT path-
way (17) we performed knockdown (kd) of p53 and POL
using previously validated si and shRNAs (17,42,45) (Fig-
ure 3, Supplementary Figure S2) and evaluated nascent
DNA elongation. p53 and POL kd caused track elonga-
tion in hESCs (Figure 3A), but shortening in both diff cell
types (Figure 3A). p53 and POL kd also affected the track
lengths of the adult and cancer nd and diff cell models, with
opposing effects depending on the differentiation status of
the cells (Figure 3B–D). Underscoring the significance of
the findings, such results were observed regardless of the use
of siRNA or shRNA or the type of POL shRNA and the
degree of protein downregulation (Figure 3E, Supplemen-
tary Figure S2).
POL acts in the same pathway as p53 and controls the ac-
tivities of downstream partners in nascent DNA elongation of
SCs and differentiated cells
While p53 in complex with POL exerts a direct role in
DDT affecting replication track lengths (17), p53 also in-
teracts with other DNA repair/replication proteins and
transcriptionally transactivates targets relevant for DDR
(9,46). Hence, we examined the expression of such p53 tar-
gets and partners. The waterfall plot in Figure 4A sum-
marizes densitometric quantifications of protein levels in
diff relative to nd cancer cells (Western Blots: Figure 4B).
p53 levels were the most different, followed by its target
p21, POL, the p53-inducible ribonucleotide-diphosphate
reductase subunit M2 B (p53R2), polymerase eta (POL)
as well as HLTF, a component of the p53-dependent DDT
pathway (17). The levels of DDT components PCNA
and ZRANB3, the base excision repair (BER) enzymes
apurinic/apyrimidinic endonuclease 1 (APE1) and DNA
polymerase beta (POL), both p53 binding proteins as well
as of another p53 target, the mouse double minute 2 ho-
molog (MDM2) did not change when comparing nd and
diff cells (Figure 3A). Of note, although both p53 and POL
are upregulated in diff cells, we did not find evidence of tran-
scriptional regulation of POL by p53 (Figure 4C).
Using previously validated shRNAs (17,47), we then
tested the influence of individual kd of the above-mentioned
proteins on the replication track length (Supplementary
Figure S3A–H). The effects of protein kd could be sepa-
rated in three groups: First, proteins which are not major
players in track length elongation such as APE1 whose kd
did not have an effect on DNA track lengths (black cir-
cles). Second, proteins affecting track length elongation in
a similar fashion in nd and diff cells such as ZRANB3 and
POL (black circles). Third, proteins, which regulate track
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Figure 2. DNA damage in SCs and their differentiated counterparts. Various DNA damage markers were investigated in nd and diff ovarian cancer cells
of line #110. Shown are mean ± SEM. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001 (A, B: Mann–Whitney U test, two-sided, D, E: Wilcoxon
matched-pairs signed rank test, two-sided). (A) Fork asymmetry of cell line #110. Measured were IdU tracks emanating from the same origin (CldU track).
Finally, the longer IdU track was divided by the shorter one. The ratio for nd and diff cells is displayed in the graph. (B) Foci analysis of H2AX and
53BP1 as well as colocalized foci after solvent (mock) or mitomycin C (MMC) treatment. Cells were treated with solvent (H2O) or 3 M MMC for 45 min
and then incubated for 3 h with medium until fixation. The graphs show the results from two independent experiments (120–200 cells/experiment). (C)
Representative pictures of H2AX, 53BP1 and colocalized foci after mock or MMC treatment. White scale bars: 10 m. (D) and (E) show results of WB
analysis and representative blots. P–x correspond to the phosphorylated forms of the indicated proteins. Individual band intensities were corrected to the
corresponding ones for the housekeeping genes -actin, ratios are formed of phosphorylated to basal proteins followed by normalization of protein levels
to nd cells. RPA (D) corresponds to replication protein A and ATR (E) corresponds to Ataxia telangiectasia and Rad3 related serine/threonine kinase.
Images are representative of 6 independent experiments.
Within the latter group, two sub-groups can be defined. The
first sub-group includes p53, POL, p21, p53R2 and MDM2
whose kd reduced replication track differences between nd
and diff cells (green circles). The second sub-group covers
POL and HLTF whose kd further amplified the difference
in DNA track lengths in the two cell types (magenta cir-
cles). Proteins in the third group could: (a) regulate the same
DDT pathway in both cell types, but with diametrically op-
posed results in nd and diff cells or (b) contribute to dif-
ferent DDT pathways. These results also demonstrate that
p53, its partners and targets differentially influence DNA
elongation in nd and diff cells. They do so in a manner that
does not, at least entirely, depend on the changes in protein
expression levels of nd versus diff cells (compare with wa-
terfall plot in Figure 4A).
To examine whether the effect of p53 is indirect and po-
tentially dependent on TA of p21, we performed a double-
kd of p53 and p21 (Figure 4D). The analysis of track lengths
revealed an additive effect of p53 kd and p21 kd. While p53
kd or p21 kd alone resulted in a 1.2- to 1.4-fold increase
in nd and a 20–30% decrease in diff cells (Figure 3C, Sup-
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Figure 3. Impact of p53 and POL expression on the average nascent DNA track length of SCs and differentiated cells. DNA Fiber Spreading Assays with
sequential incorporation of CldU (20min) and IdU (30min) in A and C and of CldU (20min) and IdU (20min) in B after kd of p53 and POL using gene
specific shRNA (sh) or siRNA (si). As controls empty vectors without sh/with scrambled sh or non-silencing si were used. For clarity protein nomenclature
was used for both genes and proteins throughout the manuscript. Experiments were conducted 24–48 h post-transfection. In (A–D): mean ± SEM. **P ≤
0.01, ****P ≤ 0.0001 (Mann–Whitney U test, two-sided). Arrows indicate the effect that a given kd causes on the average track length. Gray arrows: nd;
blue: diff. Green circles encompass the following pattern caused by the kd: lengthening effect in nd, shortening effect in diff cells. (A) Results from hESCs
(nd), differentiated into sdiff or ndiff after kd of p53 and POL by si. Data shows IdU tracks from a representative experiment of two independent ones
(100–380 fibers each). Statistics was calculated between single samples of the same lineage and between nd and diff lineages only. (B) DNA replication tracks
in HSPCs and PBLs after kd of p53 and POL by using sh. Results are the average of three independent experiments for 1–5 donors/experiment (120–530
fibers/experiment). (C) Replication phenotypes in ovarian cancer cell lines #83, #107 and #110 after kd of p53 and POL using sh. Graphs depict results
from two (#83, #110) or three (#107) independent experiments (#83: 110– 210, #107: 100–220, #110: 100–250 fibers/experiment). (D) Representative
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Figure 4. Effect of differentiation stage on protein expression and nascent DNA track length in ovarian cancer cells. For gene silencing vectors containing
specific shRNAs (sh) or empty vectors without sh/with scrambled sh were transfected into cells. 24 h post-transfection experiments were conducted. In (A,
D): mean ± SEM. *P ≤ 0.05, **P ≤ 0.01, ****P ≤ 0.0001 (A: Wilcoxon matched-pairs signed rank test, two-sided; D: Mann–Whitney U test, two-sided).
In (C), mean ± SD. Arrows indicate the effect that a given kd causes on the average track length. Gray arrows: nd, blue: diff. Green circles encompass
the following pattern caused by the kd: lengthening effect in nd and shorthening effect in diff cells. (A). Western Blot analysis in nd and diff cells. Values
were normalized to nd cells after individual corrections of band intensities with the ones from housekeeping genes (-actin, GAPDH or PCNA) and then
mean values sorted starting from the highest fold change (Waterfall plot). Quantification of 3 (APE1)–12 (POL) blots. (B) Representative western Blots for
(A). Black framed blots indicate origin from the same membrane and the same exposure. (C) Results of qRT-PCR from two independent experiments of
#110 after p53 kd. For clarity the nomenclature for proteins was used throughout the manuscript. Investigated were mRNA levels of p53, p21 and POL.
Values were normalized to means of control samples for each cell line in each experiment. (D) Results of DNA Fiber Spreading Assays with sequential
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track elongation in nd cells and in diff cells shortening by
40% (Figure 4D). Hence, both proteins exert at least par-
tially independent functions during replication of both cell
types.
Given that the replication phenotype observed in nd cells
with DNA replication slow-down was reminiscent of the
FR-DDT pathway triggered by the p53–POL idling com-
plex (17), we re-analyzed the fiber data obtained after kd
of the key components of the pathway, i.e. POL, p53 and
ZRANB3 regarding fork asymmetries (Supplementary Fig-
ure S3I–K). Strikingly, kd of all three proteins raised asym-
metries in nd cells to the elevated level observed in diff cells,
while kd in diff cells did not further increase asymmetries.
From this we conclude that POL, p53 and ZRANB3 pre-
vent fork stalling in nd cells by replication deceleration.
Next, we performed double-kd of POL, p53, HLTF and
ZRANB3 (Figure 5). Similar track length changes were
observed after single and double-kd of POL and p53 in
both cell types suggesting that both proteins act in the same
mechanisms (Figure 5A). Double-kd experiments targeting
POL together with HLTF (Figure 5B) or ZRANB3 (Fig-
ure 5C) caused track elongation in nd cells and shortening
in diff cells in the range seen after single POL kd (Fig-
ures 3C and 5A). These data indicated that POL supports
ZRANB3-dependent FR in nd cells, showing partial epis-
tasis (compare results with Supplementary Figure S3H).
In contrast in diff cells, where the effects of single POL
and ZRANB3 kd were opposite, the double-kd revealed the
dominance of POL, i.e. dependency of ZRANB3 function
on POL for track shortening. Dominance of POL over the
divergent, though moderate effects of HLTF (∼10%) (Sup-
plementary Figure S3G), was revealed in both cell types
(Figure 5B). These results substantiate epistatic relation-
ships between POL and p53 as well as between POL and
ZRANB3 in nd cells and unveiled that POL is upstream
of ZRANB3-mediated replication deceleration even in diff
cells.
POL selectively interacts with p53 and ZRANB3 in SCs
As POL influenced the DDT pathway choices in nd and
diff cells (Figure 2) and participates in p53-dependent (17),
and independent DDT (48), we explored POL protein com-
plexes in nd and diff cells using in situ Proximity Liga-
tion Assay (PLA). While POL interacted with PCNA in
both cell types (Figure 6A), it preferentially formed PLA
foci with Ser15 phosphorylated p53 (P-p53), HLTF and
ZRANB3 in nd cells (Figure 6B–D), whereas p21-POL as-
sociation was favored in diff cells (Figure 6E). The sketch
in Figure 6F depicts the changes in the POL complexes of
nd vs. diff cells. Given that the homologous recombination
factors BRCA2 and RAD51 have as well been implicated
in fork protection (49) and fork reversal (50), respectively,
we correspondingly investigated association of POL with
these proteins. While PLA foci indicated preferential asso-
ciation of POL with RAD51 in nd cells (Supplementary
Figure S4A), no differences were detected in PLA foci in-
volving BRCA2 between the two cell types (Supplementary
Figure S4B). These results supported the notion that nd but
not diff cells efficiently engage the p53–POL-mediated FR-
DDT pathway.
Given the accepted role of POL in translesion DNA
synthesis (TLS) (51), a process triggered by PCNA mono-
ubiquitination and aids track lengthening (52,53), it is pos-
sible that POL supports TLS in diff cells. TLS is regu-
lated by PCNA ubiquitination (53,54), and PCNA poly-
ubiquitination, a post-translational modification that is
particularly disfavored in diff compared with nd cells (Sup-
plementary Figure S5A), inhibits TLS (55). Knockdown
of p21, which colocalized with POL in diff cells (Figure
6E) and was reported to modulate PCNA ubiquitination
(56,57), selectively de-repressed poly-ubiquitination in diff
cells (Supplementary Figure S5B), hence suggesting that
POL mediated TLS may be favored by the endogenous
load of p21 in diff cells. Recruitment of TLS-POL to DNA
lesions can be detected by the formation of focal accumu-
lations in the chromatin (61). Immunofluorescence micro-
scopic analysis showed an increase of the average POL foci
numbers in diff compared with nd cells stemming from a
rise of the percentage of cells with excess POL foci (≥30
foci/cell) (Supplementary Figure S5C). Stress resistance is
another hallmark of cells engaging TLS (59). Comparative
assessment of cell viabilities revealed that POL kd is sig-
nificantly more detrimental to diff than to nd cells (Supple-
mentary Figure S5D). These pieces of evidence support the
likelihood that POL promotes fast DNA synthesis by TLS
in diff cells, where PCNA poly-ubiquitination is disfavored.
Chromatin immunoprecipitation after crosslinking (Co-
IP) also revealed the p53–POL and the PCNA-POL inter-
action in nd cells (Figure 7A). The interaction of PCNA
and POL was not revealed in Co-IP experiments in diff
cells, which may result from short residence times of TLS
POLs at replication sites (60). Altogether, the IP data re-
vealed the existence of different replication-relevant PCNA
protein complexes in nd and diff cells, which most probably
impact on the DDT pathway choice.
POL and ZRANB3 are enriched at decelerated replication
forks in SCs
To investigate if the protein complexes outlined in Figure 6
are associated with ongoing replication forks, we used in situ
analysis of protein interactions at DNA replication forks
(SIRF). This method combines EdU incorporation, click-
it detection of nascent DNA and a PLA protocol, allowing
detection of proteins enriched near/at ongoing replication
forks (26,27). SIRF identifies these complexes at single-cell
levels and can be advantageous when the amounts of cells
are limited, as is the case when working with SCs at lim-
ited passage numbers. SIRF was performed with the POL
partners that revealed the most pronounced decline in diff
versus nd cells in PLA assays, namely P-p53 and ZRANB3
(Figure 6B, D). First, levels of PCNA at the replication fork
(EdU) and at post-replication sites (chase) were determined
(Figure 7B). In line with the SIRF setting of Roy et al. (61) a
selective localization of PCNA to active forks was observed.
In nd cells, POL was also found in the pulse fraction (Fig-
ure 7C), which was consistent with POL-PCNA PLA data
(Figure 6A), but was surprisingly maintained on DNA af-
ter the chase. Conversely, in diff cells POL diminished in the
chase fraction (Figure 7C). This result reveals a prolonged
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Figure 5. Effect of double-knockdown of POL and candidate genes on nascent DNA track length in ovarian cancer cells. For gene silencing vectors con-
taining specific shRNAs (sh) or scrambled control sh were transfected into cells. 24h post-transfection experiments were conducted. DNA Fiber Spreading
Assays were performed by sequential incorporation of CldU (20min) and IdU (30min). In (A–C): mean ± SEM. *P ≤ 0.05, ****P ≤ 0.0001 (Mann–Whitney
U test, two-sided). Arrows indicate the effect that a given kd causes on the average track length. Grey arrows: nd, blue: diff. Green circles encompass the
following pattern caused by the kd: lengthening effect in nd and shorthening effect in diff cells. (A) Results of DNA Fiber Spreading Assays after single
kd of POL and in parallel the double-kd of p53 and POL and representative Western Blots. Data shows IdU tracks from two independent experiments
(100–230 fibers each). (B) Results of DNA Fiber Spreading Assays after double-kd of HLTF and POL and representative Western Blots. Data shows
IdU tracks from two independent experiments (100–230 fibers each). (C) Results of DNA Fiber Spreading Assays after double-kd of ZRANB3 and POL
and representative Western Blots. Data shows IdU tracks from two independent experiments (100–230 fibers each). Please note, that kd experiments for
POL only and double-kd for POL plus HLTF and POL plus ZRANB3 as well as for the alternative POL shRNA in Supplementary Figure S2D were
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Figure 6. POL association partners determined by proximity ligation assay in ovarian cancer cells. In (A), mean ± SEM. ****P ≤ 0.0001 (Mann–
Whitney U test, two-sided). White scale bars: 10 m. PLA foci analysis of POL and six other proteins within the nucleus of the cells. Shown are quan-
tification and representative pictures for (A). POL and PCNA (240–460 cells/experiment), (B) POL and p53 phosphorylated at Ser15 (P-p53) (250–360
cells/experiment), (C) POL and HLTF (210–350 cells/experiment), (D) POL and ZRANB3 (120–420 cells/experiment), (E) POL and p21 (230–310
cells/experiment). Last row of representative pictures corresponds to the negative control. (F) Schematic illustration of complex partners of POL in nd
(left panel) and diff (right panel) cells according to the quantitative results in (A–E), size of individual proteins correlates to their preference to interact
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Figure 7. Protein complexes at progressing forks in nd and diff cells of ovarian cancer cells. In (B): mean±SEM. **P ≤ 0.01, ****P ≤ 0.0001 (Mann–
Whitney U test, two-sided). (A) Representative Co-IP. Black framed blots indicate origin from same membrane and same exposure. Stippled line implies
cropping at this site. (B–E) Results of one out of two representative experiments of in situ analysis of protein complexes at DNA replication forks (SIRF).
SIRF combines EdU incorporation (8 min) and the following chase (thymidine incorporation, ≤4 h) with a click reaction and a PLA, to detect proteins
near/at ongoing replication forks. Grey columns (upper row): nd cells, blue columns (lower row): diff cells. Shown are also representative pictures (last
column correlates to negative control). White scale bars: 10m. Results for (B). PCNA (108–226 cells), for (C). POL (88–316 cells), for (D). P-p53 (130–
217 cells), for (E). ZRANB3 (148–291 cells). (F) Schematic illustration of protein complexes at nd and diff forks. Replisomes of nd cells are enriched in
POL, p53 and ZRANB3. During the chase, a fraction of the forks (PCNA positive) still binds POL and ZRANB3, potentially revealing decelerating fork
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cells, but a much more transient interaction in diff cells,
which could reflect a more classical role in TLS. P-p53 was
mainly present at the active fork in nd cells (Figure 7D) but
its detection was very low in chased nd and in diff cells. The
absence of P-p53 at progressing forks in diff cells implied
that p53 does not directly participate in the DDT of these
cells. ZRANB3 was detected at the active forks from nd cells
and was equally prominent in the chase fraction (Figure 7E)
supporting the POL–ZRANB3 interaction revealed by the
PLA (Figure 7D). The similarity in the POL and ZRANB3
pattern suggests a common role in fork deceleration. In diff
cells, almost no ZRANB3 foci were detected, implying that
the participation of ZRANB3 in the DDT of these cells is
more limited. Sketches in Figure 7F outline the interpre-
tation of the results obtained in SIRF experiments. In nd
cells, PCNA, POL, P-p53 and ZRANB3 are located at ac-
tive forks. After the chase, a POL-ZRANB3 complex may
be enriched at decelerated forks committed to FR. In diff
cells, PCNA together with POL were at active forks and to
a much lesser extent in locations behind the forks implying
that the differentiation status influences the choice between
two different DDT pathways involving POL.
DISCUSSION
While previous reports have acknowledged the role of DDT
in the maintenance of the SC status, genome stability and
cancer prevention (6) this report shows an association be-
tween the DDT pathway choice and the differentiation sta-
tus. SCs select one particular DDT pathway to cope with en-
dogenous replication stress while differentiated cells priori-
tize replication speed. Thus, SCs use a pathway depending
on POL, p53, PCNA, ZRANB3 and HLTF, which possibly
leads to a DDT mediated by FR, whereas diff cells may rely
predominantly on a more rapid DDT, possibly achieved by
POL-mediated TLS (Figure 8).
A physiological role of p53 in SCs that protects against DNA
damage
In our work, human p53 levels were generally lower in SCs
than in differentiated cells. In agreement, the TA activity
of p53 was reported to be low in SCs (12,62,63) possibly
avoiding counter-selecting mutations (63). Along with this
observation, TP53 was wild-type but TA targets such as p21
were low in the nd cell lines from ovarian cancer patients
used in our study, which were enriched for tumor-initiating
cells (20).
In addition, however, accumulating evidence indicates
that despite being low, p53 is relevant for the physiology of
SCs, in a manner that may or may not depend on its TA ac-
tivity. First, ancestors of the p53 family protect the egg and
sperm against DNA damage in invertebrates (63). Second,
depending on the mouse strain, p53-deficiency correlates
with developmental defects at birth (63). Third, in humans,
p53 protects adult SCs (15). In particular, human HSCs
need intact p53 to promote self-renewal (15). Loss of p53
was accompanied with increased spontaneous H2AX foci,
suggesting that the role of p53 in self-renewal was associated
with DNA damage prevention (15). Reminiscent of this pat-
tern, nd cells showed less DNA replication-associated dam-
age than diff cells. Augmented replication speed could be at
the source of the DNA damage of diff cells as recently sug-
gested by Maya-Mendoza and colleagues (28). Therefore, it
is conceivable that SCs enforce a mechanism to slow down
at DNA replication barriers to reduce replication stress. In
such a context, p53–POL idling and ZRANB3-mediated
FR (17) may represent an advantageous DDT choice in nd
cells.
p53 and POL directly control DNA damage tolerance to en-
sure slow fork progression in SCs
Herein we have presented evidence demonstrating that p53
and POL negatively regulate the rate of nascent DNA syn-
thesis in nd cells. The mechanism is reminiscent and builds
upon our previous works (17,64), where we noticed that
replication deceleration and homology-directed bypass of
replication barriers are dependent on p53’s exonuclease ac-
tivity and p53–POL complex formation. In analogy, we
propose that such a pathway dominates the nascent DNA
elongation program of nd cells, i.e. that POL-polymerase
and p53’s exonuclease activities together mediate such a
pathway choice by enabling idling events, which are itera-
tive insertion and removal of nucleotides (18). By slowing
fork progression, idling may generate a time-window that
favors poly-ubiquitination of PCNA and thereafter recruit-
ment of translocases. Our previous work has identified a
crucial role of ZRANB3 among several tested translocases
(SMARCAL1, BLM, WRN) in this newly discovered p53–
POL-mediated DDT pathway (17).
When assessing the contribution of different factors to
the DNA replication speed control in nd and diff cells,
we found that ZRANB3 decelerated DNA replication in
both cell types, albeit with a smaller impact on diff cells.
Given that ZRANB3 is a well-established translocase pro-
moting transiently limited fork progression and dynamic
FR (19,65,66), it is tempting to speculate that ZRANB3-
dependent FR acts downstream of p53–POL-mediated
idling in nd cells, in particular (Figure 8). Double-kd ex-
periments reinforce such a notion. In nd cells, POL- and
p53-mediated idling and ZRANB3-mediated fork slowing
contribute to track length shortening. In diff cells, where
the effects of single POL and ZRANB3 kd were opposite,
the double kd revealed dominance of POL, i.e. ZRANB3-
mediated DNA replication transactions being dependent on
POL also in these cells. From this we conclude that fork de-
celerating mechanisms are also active in diff cells and that
POL is upstream of those events as well. Unexpectedly,
these data reveal that POL is a master regulator of the dif-
ferential DDT pathway choice (neutralizing the difference
of track length between nd and diff cells and being essen-
tial for the activation of both lengthening and shortening
tolerance pathway choices in both cell types).
The functional interaction of ZRANB3 and POL in nd
cells is also supported by PLA data. To a lesser extent this
was also true for the E3 ligase HLTF and the recombi-
nase RAD51, which are both also known to promote FR
(50,59). Differently, BRCA2 showed the same association
with POL in both cell types, excluding a major role of ho-
mologous recombination or the fork protection function of
BRCA2 acting on stalled rather than transiently reversed
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Figure 8. Model of replication bypass in nd and diff cells. In non-differentiated (nd) cells (left part of the model) a small amount of p53 is expressed
(Figure 4A) supporting the p53–POL idling-mediated DDT at DNA replication impediments (red triangle) (17). Once the p53–POL complex associates
with DNA (Figures 6A, B and 7C, D), idling events give extra time for PCNA poly-ubiquitination (Supplementary Figure S5A) promoting recruitment
of downstream factors like ZRANB3 (Figures 6D and 7E) needed for symmetrically delaying forks and/or dynamic fork reversal altogether resulting in
slow, but error-free fork progression (59,65). In diff cells, higher p53 levels induce higher levels of its transcriptional targets including p21 (Figure 4A). This
change in protein expression supports a change in the pathway choice (right part of the model). In this cell type, p21 associates with PCNA (56,86) as well
as POL (Figure 6E) and antagonizes PCNA poly-ubiquitination (Supplementary Figure S5B), triggering another DDT choice, most likely TLS, which
mediates rapid but potentially mutagenic bypass of the replication barrier (48). Though the TLS bypass is active also in nd cells and fork decelerating
mechanisms also in diff cells (stippled thin arrows), POL keeps the balance such that slow replication dominates in nd and fast replication in diff cells.
Transcriptional transactivation by p53 is indicated by a stippled thick line. Green arrows in the model depict connections identified in this work, whereas
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FR can take place in both nd and diff cells, it would be fa-
vored by p53–POL complexes in nd cells. Notably however,
fork symmetry was high in nd cells in a manner depend-
ing on p53, POL and ZRANB3, just like fork deceleration.
This observation suggests that the decelerating mechanisms
in nd cells act on both sides of the replication bubble with
similar dynamics arguing against persisting FR at specific
barriers. While previous work suggested that ZRANB3 de-
celerates DNA replication by dynamic, i.e. transient fork
reversal (19), it is also conceivable that ZRANB3 as heli-
case or PCNA-stimulated endonuclease cooperates with the
p53–POL idling complex in nd cells (67). Future work will
have to provide formal evidence for the impact of FR in
p53-, POL- and ZRANB3-dependent fork slowing in nd
cells by quantitative electron microscopic imaging.
In differentiated cells POL drives a diametrically opposed
DNA damage tolerance pathway
In diff cells both p53 and POL promoted high replication
speed. This switch was accompanied with a major mecha-
nistic change, as the interaction between both proteins was
no longer required (as revealed in PLA and Co-IP experi-
ments). The associations of ZRANB3, HLTF and RAD51
with POL were also significantly reduced in diff cells, indi-
cating that a different DDT pathway was favored.
POL was reported to aid BER and key components of
this pathway, POL and APE1, are interaction partners of
p53 (68,69). APE1 kd did not reveal any influence on repli-
cation track lengths at all, POL silencing shortened DNA
track lengths regardless of the differentiation status. Since
APE1 is upstream of POL in the course of BER, the al-
terations in the DNA damage load after POL kd but not
APE1 kd could influence the track lengths. Importantly,
these data suggest that it is unlikely that POL regulates
DNA replication track lengths in nd and diff cells by BER
functions.
So far, POL has been underexplored in living cells, but
biochemical data convincingly demonstrated that it can act
as TLS polymerase (48). In general, if a specialized poly-
merase is depleted and the nascent DNA elongation result-
ing from the bypass of replication barriers is reduced, the
involvement of the TLS polymerase in the successful by-
pass of the DNA lesion is inferred (52). Given that longer
tracks in diff cells depended on POL, we propose a role of
POL in TLS events in these cells. Additional support for
this concept comes from our observations indicating that
nuclear POL foci were more readily formed and the pro-
survival effects of POL enhanced in diff cells. Altogether,
these data support the concept of a shift towards enhanced
TLS by POL in diff cells.
The kd of POL had the opposed effects on DNA tracks
in nd and diff cells when compared to the kd of POL.
Though less pronounced, the effect of POL kd was re-
capitulated by HLTF silencing. A likely explanation for
the results after HLTF kd is that HLTF, as a ubiquitin
E3 ligase and a translocase, supports several DDT path-
ways, including those involving SMARCAL1 instead of
ZRANB3 (70). HLTF has also been described to stimu-
late both PCNA mono-ubiquitination and POL-mediated
TLS in a damage-specific manner (71). Hence, it is possi-
ble that the conditions for HLTF-mediated TLS by POL
are preferentially met in nd cells and for FR in diff cells.
These alternative DDT pathways may compete with the
p53–POL-dependent one, resulting in net changes of repli-
cation tracks of only ∼10% after HLTF kd. Most impor-
tantly, DNA Fiber Spreading Assays after double-kd of
POL and HLTF revealed the same pattern and degree of
replication track changes as in single POL kd cells. These
data show that POL is required possibly upstream of the
modest changes seen after single kd of HLTF, again under-
scoring the role of POL as master regulator of the DDT
choices in nd and diff cells.
The p53 target, p21, contributes to the choice of the DNA
damage tolerance pathway
In the light of these diametrically opposed DNA replica-
tion phenotypes orchestrated by p53 in concert with POL,
it should be mentioned that both positive and negative roles
of p53 on replication track elongation have been previously
reported. As mentioned already, a role of p53 in track short-
ening was previously linked to the p53–POL idling complex
and not to TA (17,64). On the other hand, p53 was reported
to lengthen replication tracks in a manner that was depen-
dent on its TA activity (72,73). While the potential sources
for such differences are many, it is tempting to highlight that
the contrary observations recapitulate the opposed contri-
bution of p53 to the DNA elongation rate of nd vs. diff cells.
p21, p53R2 and MDM2 have been ranked as the top tran-
scriptional targets of p53 (74) and all three supported the
POL–dependent DDT pathway choices. MDM2 may con-
tribute to the replication of nascent DNA in nd and diff
cells via mechanisms such as interaction with DNA poly-
merases POL (75) or POLε (76), chromatin remodelling
(77,78) and R-loop suppression (79). p53R2 ensures the de-
oxynucleotide (dNTP) supply (80–82), which can explain
track shortening in diff cells after p53R2 kd. The track
lengthening effect after p53R2 kd in nd cells is more puz-
zling. It might be due to the imbalance of the ribonucleotide
(rNTP)/dNTP ratio disfavoring POL as compared with
POL (83,84), and compromising the exonuclease activity
of p53 (85).
The p53 target p21 is well-known to play a multifaceted
role in negatively and positively regulating DNA elonga-
tion and TLS, whereby its PCNA binding capacity is a
prerequisite and its protein level of critical importance
(28,36,56,58,86,87). Our single and double-kd experiments
revealed that p21 exerts at least partially distinct functions
from p53 in the DDT pathway choice. While in diff cells
the formation of a POL-p21 complex may facilitate the
use of POL for TLS, in nd cells p21 indirectly supports
p53–POL–mediated idling. Intriguingly, up- and down-
modulation of p21 were reported to stimulate PCNA ubiq-
uitination (56,57). Here, we observed that p21 counter-
acts poly-ubiquitination of PCNA in diff cells in particu-
lar, which is in line with reduced levels of poly-ubiquitinated
PCNA in these cells. Given that PCNA is involved in TLS
in its mono-ubiquitinated form and in FR-DDT in its poly-
ubiquitinated form (53), these data strengthen the concept
that POL facilitates TLS in diff and FR-DDT in nd cells.
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in diff cells might play a decisive role in modulating the for-
mation of POL protein complexes. Altogether, we propose
that ZRANB3 is recruited to PCNA at sites, where p53–
POL-mediated idling delays replication fork progression
thereby promoting poly-ubiquitination (17), which is antag-
onized in diff cells because of a lack of p53–POL-mediated
idling and by an augmentation of p21 in diff cells (Figure
8).
CONCLUSIONS
Herein we report that the differentiation status leads to slow
replication in SCs and fast replication in diff cells. Remark-
ably, p53 and POL are key to both replication choices al-
beit because of different mechanisms. In SCs, p53 triggers
an idling process in concert with POL, giving the replica-
tion forks time to accumulate PCNA poly-ubiquitination
and recruit factors such as ZRANB3 resulting in symmetri-
cally delayed and/or dynamic FR-mediated slow-down of
DNA replication, which is expected to be error-free (Fig-
ure 8, left part). In differentiated cells, p53 indirectly pro-
motes p21-POL association. PCNA-polyubiquitination is
antagonized, most likely by p21, thereafter boosting DNA
replication speed in a manner that depends on POL, very
likely by POL-mediated TLS, which should be a mutagenic
type of tolerance event (Figure 8, right part). Such a path-
way choice may be relevant, as the choice of a safe bypass
of replication barriers is particularly desirable for long-lived
SCs with the potential of replenishing the pool of short-
lived diff cells. This concept is in agreements with works
by others revealing that fork remodeling prevents unre-
strained replication driven by potentially mutagenic mech-
anisms like TLS (59,87). Our work highlights that the DNA
replication program in SCs is not recapitulated in diff cells,
thereby suggesting that selectively targeting the DDT path-
way of SCs may be relevant for therapies targeting cancer
cells bearing stem-cell-like features.
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33. González Besteiro,M.A., Calzetta,N.L., Loureiro,S.M., Habif,M.,
Bétous,R., Pillaire,M.J., Maffia,A., Sabbioneda,S., Hoffmann,J.S.
and Gottifredi,V. (2019) Chk1 loss creates replication barriers that
compromise cell survival independently of excess origin firing. EMBO
J., 38, e101284.
34. Petermann,E., Woodcock,M. and Helleday,T. (2010) Chk1 promotes
replication fork progression by controlling replication initiation. Proc.
Natl Acad. Sci. U.S.A., 107, 16090–16095.
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